NDC 62332-175 – Fesoterodine Fumarate

Fesoterodine Fumarate 4 mg/1 · Tablet, Extended Release · Oral

Human Prescription Drug 2 recalls

Product NDC62332-175

Product details

Brand name
Fesoterodine Fumarate
Generic name
Fesoterodine Fumarate
Labeler
Alembic Pharmaceuticals Inc.
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA204973
Marketed since
January 6, 2023
Listing expires
December 31, 2026

Active ingredients

Uses, dosage, side effects and warnings for Fesoterodine Fumarate →

Package NDC codes (4)

Package NDCDescriptionSince
62332-175-10100 TABLET, EXTENDED RELEASE in 1 CARTON (62332-175-10)Jan 6, 2023
62332-175-3030 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-175-30)Jan 6, 2023
62332-175-9090 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-175-90)Jan 6, 2023
62332-175-911000 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-175-91)Jan 6, 2023

Recalls mentioning this NDC

Other Fesoterodine Fumarate products